Abeona Therapeutics CFO Executes Stock Sales Amidst Q1 Earnings Beat
Abeona Therapeutics Inc. (NASDAQ: ABEO) Chief Financial Officer Joseph Vazzano has executed a series of stock sales totaling $265,242 in early June 2026. These transactions were primarily structured to satisfy tax obligations related to restricted stock vesting. Concurrently, the company reported its first-quarter 2026 financial results, which demo…